2013

Silveirinha de Oliveira , E., Aspinall, P., Briggs, A., Cummins, S., Leyland, A., Mitchell, R., Roe, J., and Ward Thompson, C. (2013) How effective is the Forestry Commission Scotland's woodland improvement programme—‘Woods In and Around Towns’ (WIAT)—at improving psychological well-being in deprived urban communities? A quasi-experimental study. BMJ Open, 3 (8). e003648. ISSN 2044-6055 (doi:10.1136/bmjopen-2013-003648)

Looker, H.C. et al. (2013) Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia, 56 (8). pp. 1716-1725. ISSN 0012-186X (doi:10.1007/s00125-013-2928-7)

Roberts, N.J., Lewsey, J.D., Gillies, M., Briggs, A.H., Belozeroff, V., Globe, D.R., Chiou, C., Lin, S., and Globe, G. (2013) Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: a retrospective cohort study from 1981 to 2009. Respiratory Medicine, 107 (8). pp. 1172-1177. ISSN 0954-6111 (doi:10.1016/j.rmed.2013.04.004)

Tigbe, W.W., Briggs, A.H., and Lean, M.E.J. (2013) A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK Counterweight programme. International Journal of Obesity, 37 (8). pp. 1135-1139. ISSN 0307-0565 (doi:10.1038/ijo.2012.186)

Murphy, A., Fenwick, E., Toff, W.D., Neilson, M.P., Berry, C., Uren, N., Oldroyd, K.G., and Briggs, A.H. (2013) Transcatheter aortic valve implantation for severe aortic stenosis: the cost-effectiveness case for inoperable patients in the United Kingdom. International Journal of Technology Assessment in Health Care, 29 (01). pp. 12-19. ISSN 0266-4623 (doi:10.1017/S0266462312000670)

Boyd, K., and Briggs, A. (2013) Statistical issues with trial data and economic modeling for cost-effectiveness evaluation. In: Tang, W. and Tu, X. (eds.) Modern Clinical Trial Analysis. Series: Applied bioinformatics and biostatistics in cancer research . Springer-Verlag, New York, NY, USA, pp. 149-166. ISBN 9781461443216

Davies, C., Briggs, A., Lorgelly, P., Garellick, G., and Malchau, H. (2013) The "hazards" of extrapolating survival curves. Medical Decision Making, 33 (3). pp. 369-380. ISSN 0272-989X (doi:10.1177/0272989X12475091)

Grutters, J.P.C., Sculpher, M., Briggs, A.H., Severens, J.L., Candel, M.J., Stahl, J.E., de Ruysscher, D., Boer, A., Ramaekers, B.L.T., and Joore, M.A. (2013) Acknowledging patient heterogeneity in economic evaluation. PharmacoEconomics, 31 (2). pp. 111-123. ISSN 1170-7690 (doi:10.1007/s40273-012-0015-4)

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J., and Loder, E. (2013) Consolidated Health Economic Evaluation Reporting Standards (CHEERS) - explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value in Health, 16 (2). pp. 231-250. ISSN 1098-3015 (doi:10.1016/j.jval.2013.02.002)

Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A.H., Mauskopf, J., and Loder, E. (2013) Consolidated health economic evaluation reporting standards (CHEERS) statement. British Medical Journal, 346 (f1049). ISSN 0959-535X (doi:10.1136/bmj.f1049)

Roberts, N.J., Lewsey, J.D., Gillies, M., Briggs, A.H., Belozeroff, V., Globe, D.R., Chiou, C.-F., Lin, S.-L., and Globe, G. (2013) Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: a retrospective cohort study from 1981-2009. Respiratory Medicine . ISSN 0954-6111 (doi:10.1016/j.rmed.2013.04.004) (In Press)

2012

Geue, C., Lewsey, J., Lorgelly, P., Govan, L., Hart, C., and Briggs, A. (2012) Spoilt for choice: implications of costing hospital episode statistics. Health Economics, 21 (10). pp. 1201-1216. ISSN 1057-9230 (doi:10.1002/hec.1785)

Briggs, A.H., Weinstein, M.C., Fenwick, E.A.L., Karnon, J., Sculpher, M.J., and Paltiel, A.D. (2012) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6. Value in Health, 15 (6). pp. 835-842. ISSN 1098-3015 (doi:10.1016/j.jval.2012.04.014)

Caro, J.J., Briggs, A.H., Siebert, U., and Kuntz, K.M. (2012) modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value in Health, 15 (6). pp. 796-803. ISSN 1098-3015 (doi:10.1016/j.jval.2012.06.012)

Wu, O., Briggs, A., and MacIntyre, K. (2012) Mobile phone use for contacting emergency services in life-threatening circumstances. Journal of Emergency Medicine, 42 (3). pp. 291-298. ISSN 0736-4679 (doi:10.1016/j.jemermed.2011.02.022)

Briggs, A. (2012) The ends justify the mean: outcome measures for estimating the value of new cancer therapies. Health Outcomes Research in Medicine, 3 (1). e25-e26. ISSN 1877-1319 (doi:10.1016/j.ehrm.2012.01.001)

Briggs, A.H., Weinstein, M.C., Fenwick, E.A.L., Karnon, J., Sculpher, M.J., and Paltiel, A.D. (2012) Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group - 6. Medical Decision Making, 32 (5). pp. 722-732. ISSN 0272-989X (doi:10.1177/0272989X12458348)

Caro, J.J., Briggs, A.H., Siebert, U., and Kuntz, K.M. (2012) Modeling good research practices - overview: a report of the ISPOR-SMDM modeling good research practices task force - 1. Medical Decision Making, 32 (5). pp. 667-677. ISSN 0272-989X (doi:10.1177/0272989X12454577)

Govan, L. et al. (2012) The effect of deprivation and HbA1c on admission to hospital for diabetic ketoacidosis in type 1 diabetes. Diabetologia, 55 (9). pp. 2356-2360. ISSN 0012-186X (doi:10.1007/s00125-012-2601-6)

Roberts, N.J., Boyd, K., Briggs, A.H., Caress, A.L., and Partridge, M.R. (2012) Nurse led versus lay educators support for those with asthma in primary care: a costing study. BMC Pulmonary Medicine, 12 (52). ISSN 1471-2466 (doi:10.1186/1471-2466-12-52)

Tappin, D.M. et al. (2012) The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial. Trials, 13 (113). ISSN 1745-6215 (doi:10.1186/1745-6215-13-113)

2011

McLean, R.C., Briggs, A.H., Slack, R., Zamvar, V., Berg, G.A., El-Shafei, H., Oldroyd, K.G, and Pell, J.P. (2011) Perioperative and long-term outcomes following aortic valve replacement: a population cohort study of 4124 consecutive patients. European Journal of Cardio-Thoracic Surgery, 40 (6). pp. 1508-1514. ISSN 1010-7940 (doi:10.1016/j.ejcts.2011.01.088)

Boyd, K.A., Briggs, A.H., Fenwick, E., Norrie, J., and Stock, S. (2011) Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemporary Clinical Trials, 32 (6). pp. 893-901. ISSN 1551-7144 (doi:10.1016/j.cct.2011.07.007)

Govan, L. et al. (2011) Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care, 34 (9). pp. 1992-1997. ISSN 0149-5992 (doi:10.2337/dc10-2099)

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11 (1). p. 38. ISSN 1471-2377 (doi:10.1186/1471-2377-11-38)

Price, M.J., Welton, N.J., Briggs, A.H., and Ades, A.E. (2011) Model averaging in the presence of structural uncertainty about treatment effects: influence on treatment decision and expected value of information. Value in Health, 14 (2). pp. 205-218. ISSN 1098-3015 (doi:10.1016/j.jval.2010.08.001)

Starkie, H.J., Briggs, A.H., Chambers, M.G., and Jones, P. (2011) Predicting EQ-5D Values Using the SGRQ. Value in Health, 14 (2). pp. 354-360. ISSN 1098-3015 (doi:10.1016/j.jval.2010.09.011)

Bauld, L., Boyd, K. A., Briggs, A. H., Chesterman, J., Ferguson, J., Judge, K., and Hiscock, R. (2011) One-Year Outcomes and a Cost-Effectiveness Analysis for Smokers Accessing Group-Based and Pharmacy-Led Cessation Services. Nicotine and Tobacco Research, 13 (2). pp. 135-145. ISSN 1462-2203 (doi:10.1093/ntr/ntq222)

Barton, P., Andronis, L., Briggs, A., McPherson, K., and Capewell, S. (2011) Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. British Medical Journal, 343 . d4044. ISSN 0959-535X (doi:10.1136/bmj.d4044)

Bousquet, J. et al. (2011) How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA²LEN statement. Allergy, 66 (6). pp. 765-774. ISSN 0105-4538 (doi:10.1111/j.1398-9995.2011.02590.x)

Boyd, K.A., Briggs, A., Paul, J., Iveson, T., Midgely, R., Harkin, A., Bates, G., Alexander, L., and Cassidy, J. (2011) Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting? Trials, 12 . A41. ISSN 1745-6215 (doi:10.1186/1745-6215-12-S1-A41)

Cummins, E., Asseburg, C., Punekar, Y.S., Shore, E., Morris, J., Briggs, A., and Fenwick, E.L. (2011) Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis. Value in Health, 14 (1). pp. 15-23. ISSN 1098-3015 (doi:10.1016/j.jval.2010.10.016 )

Govan, L. et al. (2011) Inpatient costs for people with type 1 and type 2 diabetes in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia, 54 (8). pp. 2000-2008. ISSN 0012-186X (doi:10.1007/s00125-011-2176-7)

2010

Boyd, K.A., Fenwick, E., and Briggs, A. (2010) Using an iterative approach to economic evaluation in the drug development process. Drug Development Research, 71 (8). pp. 470-477. ISSN 0272-4391 (doi:10.1002/ddr.20421)

Mihaylova, B., Briggs, A., O'Hagan, A., and Thompson, S.G. (2010) Review of statistical methods for analysing healthcare resources and costs. Health Economics, 20 (8). pp. 897-916. ISSN 1057-9230 (doi:10.1002/hec.1653)

Briggs, A.H., Glick, H.A., Lozano-Ortega, G., Spencer, M., Calverley, P.M.A., Jones, P.W., and Vestbo, J. (2010) Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. European Respiratory Journal, 35 (3). pp. 532-539. ISSN 0903-1936 (doi:10.1183/09031936.00153108)

Briggs, A., Ritchie, K., Fenwick, E., Chalkidou, K., and Littlejohns, P. (2010) Access with evidence development in the UK past experience, current initiatives and future potential. PharmacoEconomics, 28 (2). pp. 163-170. ISSN 1170-7690 (doi:10.2165/11531410-000000000-00000)

Lorgelly, P.K. et al. (2010) An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European Journal of Heart Failure, 12 (1). pp. 66-74. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp172)

Briggs, A.H. (2010) Transportability of comparative effectiveness and cost-effectiveness between countries. Value in Health, 13 . S22-S25. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2010.00751.x)

Campbell, H.E., Gray, A.M., Harris, A.L., Briggs, A.H., and Taylor, M.A. (2010) Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. British Journal of Cancer, 103 (6). pp. 776-786. ISSN 0007-0920 (doi:10.1038/sj.bjc.6605863)

Crott, R., and Briggs, A. (2010) Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. European Journal of Health Economics, 11 (4). pp. 427-434. ISSN 1618-7598 (doi:10.1007/s10198-010-0233-7)

Dolan, G.P., Stone, D.H., and Briggs, A. (2010) A systematic review of continuous performance task research in children prenatally exposed to alcohol. Alcohol and Alcoholism, 45 (1). pp. 30-38. ISSN 0735-0414 (doi:10.1093/alcalc/agp062)

Hollingworth, W., Campbell, J.D., Kowalski, J., Ravelo, A., Girod, I., Briggs, A., and Sullivan, S.D. (2010) Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Quality of Life Research, 19 (3). pp. 323-331. ISSN 0962-9343 (doi:10.1007/s11136-010-9590-z)

Johnston, K.M., Levy, A.R., Lima, V.D., Hogg, R.S., Tyndall, M.W, Gustafson, P., Briggs, A.H., and Montaner, J.S. (2010) Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS, 24 (12). pp. 1929-1935. ISSN 0269-9370 (doi:10.1097/QAD.0b013e32833af85d)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, 81 (2). pp. 1301-1305. ISSN 0022-3050 (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8 (23). ISSN 1741-7015 (doi:10.1186/1741-7015-8-23)

Lorgelly, P.K., Lawson, .D., Fenwick, E.A.L., and Briggs, A.H. (2010) Outcome Measurement in Economic Evaluations of Public Health Interventions: a Role for the Capability Approach? International Journal of Environmental Research and Public Health, 7 (5). pp. 2274-2289. ISSN 1660-4601 (doi:10.3390/ijerph7052274)

2009

Levy, A., Harrigan, B., Johnston, K., and Briggs, A. (2009) Comparative effectiveness research through the looking glass. Medical Decision Making, 29 (6). NP6-NP8. ISSN 0272-989X (doi:10.1177/0272989X09351590)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2 (5). pp. 475-483. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.825968)

Wu, O., Levy, A.R., Briggs, A., Lewis, G., and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87 (9). pp. 1330-1339. ISSN 0041-1337 (doi:10.1097/TP.0b013e3181a236e0)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40 (4). pp. 1038-1043. ISSN 0039-2499 (doi:10.1161/STROKEAHA.108.542787)

Mihaylova, B., Briggs, A., Hlatky, M., Armitage, J., Parish, S., Gray, A., and Collins, R. (2009) Statin cost-effectiveness in the United States for people at different vascular risk levels. Circulation: Cardiovascular Quality and Outcomes, 2 (2). pp. 65-72. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.808469)

Boyd, K.A., and Briggs, A.H. (2009) Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow. Addiction, 104 (2). pp. 317-325. ISSN 0965-2140 (doi:10.1111/j.1360-0443.2008.02449.x)

Briggs, A., Starkie, H., and Wu, O. (2009) Health economics in asthma and COPD. In: Barnes, P.J., Drazen, J.M., Rennard, S.I. and Thomson, N.C. (eds.) Asthma and COPD. Academic Press/Elsevier,, London, pp. 751-760. ISBN 9780123740014

Jacobs-van der Bruggen, M.A.M., van Baal, P.H., Hoogenveen, R.T., Feenstra, T.L., Briggs, A.H., Lawson, K., Feskens, E.J.M., and Baan, C.A. (2009) Cost-effectiveness of lifestyle modification in diabetes patients. Diabetes care, 32 (8). pp. 1453-1458. ISSN 0149-5992 (doi:10.2337/dc09-0363 )

Levy, A.R., Szabo, S., Briggs, A., Pleil, A., Davie, A., Zlateva, G., and Javitt, J. (2009) Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmology, 2009 . p. 540431. ISSN 2090-004X (doi:10.1155/2009/540431)

Levy, A.R., Szabo, S., Briggs, A., Pleil, A., Davie, A., Zlateva, G., and Javitt, J. (2009) Joint Assessment of Intended and Unintended Effects of Medications: An Example Using Vascular Endothelial Growth Factor Inhibitors for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmology, 2009 . ISSN 2090-004X (doi:10.1155/2009/540431)

2008

Barton, G.R., Briggs, A.H., and Fenwick, E.A.L. (2008) Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health, 11 (5). pp. 886-897. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2008.00358.x)

Briggs, A.H., Spencer, M., Wang, H., Mannino, D., and Sin, D.D. (2008) Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Archives of Internal Medicine, 168 (1). pp. 71-79. ISSN 0003-9926 (doi:10.1001/archinternmed.2007.37)

Briggs, A., Wild, D., Lees, M., Reaney, M., Dursun, S., Parry, D., and Mukherjee, J. (2008) Impact of schizophrenia and schizophrenia treatment related adverse events on quality of life: direct utility elicitation. Health and Quality of Life Outcomes, 6 (105). pp. 1-9. ISSN 1477-7525 (doi:10.1186/1477-7525-6-105)

Claxton, K., Briggs, A.H., Buxton, M.J., Culyer, A.J., McCabe, C., Walker, S., and Sculpher, M.J. (2008) Value based pricing for NHS drugs: an opportunity not to be missed? British Medical Journal, 336 (7638). pp. 251-254. ISSN 0959-535X (doi:10.1136/bmj.39434.500185.25)

Eckerman, S., Briggs, A., and Willan, A.R. (2008) Health technology assessment in the cost-disutility plane. Medical Decision Making, 28 (2). pp. 172-181. ISSN 0272-989X (doi:10.1177/0272989X07312474)

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) The HOPEFUL Study: a multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation (UAE) for the treatment of symptomatic uterine fibroids. Health Technology Assessment, 123 (5). pp. 1-248. ISSN 1366-5278

Hirst, A., Dutton, S., Wu, O., Briggs, A., Edwards, C., Waldenmaier, L., Maresh, M., Nicholson, A., and McPherson, K. (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technology Assessment (Winchester, England), 12 (5). 1-227, xi. ISSN 1366-5278 (doi:10.3310/hta12050)

Levy, A.R., Kowdley, K., Iloeje, U.H., Tafesse, E., Mukherjee, J., Gish, R., Bzowej, N., and Briggs, A.H. (2008) The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected person. Value in Health, 11 (3). pp. 527-538. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2007.00297.x)

Starkie, H., Briggs, A.H., and Chamber, M.G. (2008) Pharmacoeconomics in COPD: lessons for the future. Interntaional Journal of COPD, 3 (1). pp. 71-88.

2007

Campbell, H., Briggs, A.H., Buxton, M., Kim, L., and Thompson, S. (2007) The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services Research and Policy, 12 (1). pp. 11-17. ISSN 1355-8196 (doi:10.1258/135581907779497594)

Briggs, AH et al. (2007) Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart, 93 (9). pp. 1081-1086.

Campbell, H, Briggs, AH, Buxton, M, Kim, L, and Thompson, S (2007) The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm. Journal of Health Services Research and Policy, 12 (1). pp. 11-17. (doi:10.1258/135581907779497594)

Culyer, A., McCabe, C., Briggs, A.H., Claxton, K., Buxton, M., Akehurst, R., Sculpher, M.J., and Brazier, J. (2007) Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy, 12 (1). pp. 56-58.

Kim, LG, Thompson, SG, Briggs, AH, Buxton, MJ, and Campbell, H (2007) How cost-effective is screening for abdominal aortic aneurysms? Journal of Medical Screening, 14 (1). pp. 46-52.

Luc, G, Ades, AE, Sutton, AJ, Cooper, NJ, BriggS, AH, and Caldwell, DM (2007) Meta-analysis of mixed treatment comparisons at multiple follow-up times. Statistics in Medicine, 26 . pp. 3681-3699. (doi:10.1002/sim.2831)

Ossa, D.F., Briggs, A.H., McIntosh, E., Cowell, W., Littlewood, T., and Sculpher, M.J. (2007) Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods. PharmacoEconomics, 25 (3). pp. 223-237. ISSN 1170-7690

2006

Mihaylova, B., Briggs, A.H., Armitage, J., Parish, S., Gray, A., and Collins, R. (2006) Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people. British Medical Journal, 333 (7579). p. 1145. ISSN 0959-535X (doi:10.1136/bmj.38993.731725.BE)

Paul, J., Briggs, A., Harking, A., Hayclon, M., Iveson, T., Masterson, M., Midgley, A., and Cassidy, J. (2006) SCOT: short course oncology therapy — a comparison of 12 and 24 weeks of adjuvant chemotherapy in colorectal cancer. In: 2011 ASCO Annual Meeting, 3-7 Jun 2011, Chicago, Ill, USA.

Briggs, A.H., Bousquet, J., Wallace, M., Busse, W.W., Clark, T.J.H., Pedersen, S.E., and Baternan, E.D. (2006) Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy, 61 (5). pp. 531-536. ISSN 0105-4538 (doi:10.1111/j.1398-9995.2006.01038.x)

Briggs, A.H., and Levy, A.R. (2006) Pharmacoeconomics and pharmacoepidemiology - Curious bedfellows or a match made in heaven? PharmacoEconomics, 24 . pp. 1079-1086. ISSN 1170-7690

Briggs, A.H., Lozano-Ortega, G., Spencer, S., Bale, G., Spencer, M.D., and Burge, S. (2006) Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data. Value in Health, 9 (4). pp. 227-235. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2006.00106.x)

Deckers, JW, Goedhart, DM, Boersma, E, Briggs, AH, Bertrand, M, Ferrari, R, Remme, WJ, Fox, K, and imoons, ML (2006) Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. European Heart Journal, 27 . pp. 796-801. (doi:10.1093/eurheartj/ehi809)

Williams, C et al. (2006) Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. Health Technology Assessment, 10 . 1-+.

2005

Manca, A., Rice, N., Sculpher, M.J., and Briggs, A.H. (2005) Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Economics, 14 (5). pp. 471-485. ISSN 1057-9230 (doi:10.1002/hec.914)

Claxton, K., Sculpher, M., McCabe, C., Briggs, A.H., Akehurst, R., Buxton, M., Brazier, J., and O'Hagan, T. (2005) Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Economics, 14 (4). pp. 339-347. ISSN 1057-9230 (doi:10.1002/hec.985)

Briggs, A.H. (2005) Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value in Health, 8 (1). pp. 1-2. ISSN 1098-3015 (doi:10.1111/j.1524-4733.2005.08101.x)

Briggs, A.H., Nixon, R., Dixon, S., and Thompson, S. (2005) Parametric modelling of cost data: some simulation evidence. Health Economics, 14 (4). pp. 421-428. ISSN 1057-9230 (doi:10.1002/hec.941)

Briggs, AH (2005) Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty. Value in Health, 8 (1). pp. 1-2.

Clarke, PM, Gray, A, Briggs, AH, Stevens, RJ, Matthews, DR, and Holman, RR (2005) Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Diabetologia, 48 (5). pp. 868-877.

Gagnon, YM, Levy, AR, Spencer, MD, Hurley, JS, Frost, FJ, Mapel, DW, and Briggs, AH (2005) Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization. Respiratory Medicine, 99 (12). pp. 1534-1545.

Manca, A, Rice, N, Sculpher, MJ, and Briggs, AH (2005) Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models.[erratum appears in Health Econ. Health Economics, 14 (5). pp. 471-485.

Mihaylova, B, Briggs, AH, Armitage, J, Parish, S, Gary, A, and Collins, R (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet, 365 (9473). pp. 1779-1785.

O'Hagan, T. et al. (2005) Incorporation of uncertainty in health economic modelling studies. PharmacoEconomics, 23 (6). pp. 529-536. ISSN 1170-7690

Ramsey, S et al. (2005) Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value in Health, 8 (5). pp. 521-533.

Reed, S et al. (2005) Conducting economic evaluations alongside multinational clinical trials: toward a research consensus. American Heart Journal, 149 (3). pp. 434-443.

Spencer, M.D., Briggs, A.H., Grossman, R.J., and Rance, L. (2005) Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease. PharmacoEconomics, 23 (6). pp. 619-637. ISSN 1170-7690

2004

Clarke, P.M., Gray, A.M., Briggs, A., Farmer, A.J., Fenn, P,, Stevenson, R.J., Matthews, D.R., Stratton, I.M., and Holman, R.R. (2004) A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia, 47 (10). pp. 1747-1759. ISSN 1432-0428 (doi:10.1007/s00125-004-1527-z)

Briggs, A.H. (2004) Statistical approaches to handling uncertainty in health economic evaluation. Psychiatrist, 16 (6). pp. 551-561. ISSN 1758-3209

Briggs, AH (2004) Statistical approaches to handling uncertainty in health economic evaluation. [29 refs]. European Journal of Gastroenterology and Hepatology, 16 (6). pp. 551-561. ISSN 0954-691X

Briggs, AH, Sculpher, MJ, Dawson, J, Fitzpatrick, R, Murray, D, and Malchau, H (2004) The Use of Probabilistic Decision Models in Technology Assessment: The Case of Total Hip Replacement. Applied Health Economics and Health Policy, 3 (2). pp. 78-79.

Clarke, PM, Gray, A, Briggs, AH, Farmer, AJ, Fenn, P, Stevens, RJ, Matthews, DR, Stratton, IM, and Holman, R (2004) A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia, 47 . pp. 1747-1759. (doi:10.1007/s00125-004-1527-z)

Gagnon, YM, Levy, AR, Iloeje, UH, and Briggs, AH (2004) Treatment costs in Canada of health conditions resulting from chronic Hepatitis B infection. Journal of Clinical Gastroenterology, 38 (Suppl ). S179-S186.

Willan, A, Briggs, AH, and Hoch, JS (2004) Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics, 13 (5). pp. 461-475.

2003

Clarke, P., Gray, A., Legood, R., Briggs, A., and Holman, R. (2003) The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabetic Medicine, 20 (6). pp. 442-450. ISSN 0742-3071 (doi:10.1046/j.1464-5491.2003.00972.x)

Reed, S.D., Dillingham, P.W., Briggs, A.H., Veestra, D.L., and Sullivan, S.D. (2003) A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results. Medical Decision Making, 23 (3). pp. 252-264. ISSN 0272-989X (doi:10.1177/0272989X03023003007)

Briggs, AH, Ades, AE, and Price, MJ (2003) Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework. Medical Decision Making, 23 (4). pp. 341-350.

Briggs, AH, Clark, T, Wolstenholme, J, and Clark, PM (2003) Missing ... presumed at random: cost analysis of incomplete data. Health Economics, 12 (5). pp. 377-393.

Craig, D. et al. (2003) New BMJ policy on economic evaluations. Economic evaluations should be judged on economic merit. British Medical Journal, 326 (7386). p. 445. ISSN 0959-535X

Hoch, JS, Briggs, AH, and Willan, AR (2003) Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics, 11 (5). pp. 415-430.

Hope, A, and Briggs, AH (2003) Concerns regarding the ISPOR Code of Ethics for Researchers. Value in Health, 7 (4). pp. 510-511.

Tytgat, GN, Heading, RC, Muller-Lissner, S, Kamm, MA, Scholmerich, J, Berstad, A, Fried, M, Chaussade, S, Jewell, D, and Briggs, AH (2003) Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Alimentary Pharmacology and Therapeutics, 18 (3). pp. 291-301. ISSN 0269-2813 (doi:10.1046/j.1365-2036.2003.01679.x)

2002

Briggs, A., Clark, T., Wolstenholme, J., and Clarke, P. (2002) Missing.... presumed at random: cost-analysis of incomplete data. Health Economics, 12 (5). pp. 377-392. ISSN 1057-9230 (doi:10.1002/hec.766)

O'Brien, B.J., and Briggs, A.H. (2002) Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research, 11 (6). pp. 455-468. ISSN 0962-2802 (doi:10.1191/0962280202sm304ra)

Briggs, A.H., O'Brien, B.J., and Blackhouse, G. (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23 . pp. 377-401. ISSN 0163-7525 (doi:10.1146/annurev.publhealth.23.100901.140534)

Blackhouse, G., Briggs, A., and O'Brien, B.J. (2002) A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 (2). pp. 173-177. ISSN 0272-989X (doi:10.1177/02729890222063053)

Blackhouse, G, Briggs, AH, and O'Brien, BJ (2002) Estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 . pp. 170-174.

Blackhouse, G, Briggs, AH, and O'Brien, BJ (2002) A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored. Medical Decision Making, 22 (2). pp. 173-177.

Briggs, A.H., Goeree, R., Blackhouse, G., and O'Brien, B.J. (2002) Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making, 22 (4). pp. 290-308. ISSN 0272-989X (doi:10.1177/027298902400448867)

Briggs, AH, Goeree, R, and O'Brien, BJ (2002) Probabilistic analysis of models: choosing between treatment strategies for gastroesophageal reflux disease. Medical Decision Making, 22 (4). pp. 290-308.

Briggs, AH, O'Brien, BJ, and Blackhouse, G (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23 . pp. 377-401.

Goeree, R, O'Brien, BJ, Blackhouse, G, Marshall, J, Briggs, AH, and Lad, R (2002) Cost-effectiveness and cost-utility of long-term management strategies for heartburn. Value in Health, 5 (4). pp. 312-328.

O'Brien, BJ, and Briggs, AH (2002) Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Statistical Methods in Medical Research, 11 (6). pp. 455-468.

Price, M.J., and Briggs, A.H. (2002) Development of an economic model to assess the cost effectiveness of asthma management strategies. PharmacoEconomics, 20 (3). pp. 183-194. ISSN 1170-7690

2001

Sendi, P.P., and Briggs, A.H. (2001) Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane. Health Economics, 10 (7). pp. 675-680. ISSN 1057-9230 (doi:10.1002/hec.639)

Briggs, A.H., and O'Brien, B.J. (2001) The death of cost-minimization analysis? Health Economics, 10 (2). pp. 179-184. ISSN 1057-9230 (doi:10.1002/hec.584)

Briggs, A. (2001) A Bayesian approach to stochastic cost-effectiveness analysis. International Journal of Technology Assessment in Health Care, 17 (1). pp. 69-82. ISSN 0266-4623

Briggs, AH (2001) A Bayesian approach to stochastic cost-effectiveness analysis. An illustration and application to blood pressure control in type 2 diabetes. International Journal of Technology Assessment in Health Care, 17 (1). pp. 69-82.

Briggs, AH, and O'Brien, BJ (2001) The death of cost-minimization analysis?. [23 refs]. Health Economics, 10 (2). pp. 179-184.

Briggs, AH, and Tambour, M (2001) The design and analysis of stochastic cost-effectiveness studies for the evaluation of health care interventions. Drug Information Journal, 35 (4). pp. 1455-1468.

Delaney, B.C., Wilson, S.L., Roalfe, A., Briggs, A.H., and Hobbs, F.D.R. (2001) Empirical treatment or prompt endoscopy? - author's reply. Lancet, 357 . p. 1366. ISSN 0140-6736 (doi:10.1016/S0140-6736(00)04492-5)

Glick, HA, and Briggs, AH (2001) Cost-effectiveness of health care interventions: a guide to quantifying stochastic uncertainty and presenting the result of cost-effectiveness analyses. Expert Reviews in Pharmacoeconomics and Outcomes Research, 1 (1). pp. 25-36.

Levy, AR, Briggs, AH, Demers, C, and O'Brien, BJ (2001) Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada. American Heart Journal, 142 (3). pp. 537-543.